Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron

This publication has 29 references indexed in Scilit:

• Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and Vomiting
  Annals of Internal Medicine, 1990
• Comparison of the 5-Hydroxytryptamine₃(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis
  New England Journal of Medicine, 1990
• Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting
  New England Journal of Medicine, 1990
• Therapierefraktäre Emesis unter Cisplatin
  Oncology Research and Treatment, 1990
• High-Dose Metoclopramide and Chlorpromazine in the Treatment of Cisplatin-induced Emesis
  Basic & Clinical Pharmacology & Toxicology, 1987
• Review: The Management of Nausea and Vomiting in Clinical Oncology
  The Lancet Healthy Longevity, 1987
• Doxorubicin plus cisplatin in the treatment of apudomas
  Cancer, 1985
• Oncologistsʼ views of cancer patient noncompliance
  American Journal of Clinical Oncology, 1983
• On the receiving end—patient perception of the side-effects of cancer chemotherapy
  European Journal of Cancer and Clinical Oncology, 1983
• Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting
  New England Journal of Medicine, 1981